The Alliance for Connected Care submitted input on the Office of National Drug Control Policy’s 2026 National Drug Control Strategy. The Alliance emphasized the importance of maintaining comprehensive access to telehealth, because it is often an essential part of treatment for mental health conditions and substance use disorders and supports long-term recovery. The Alliance urged ONDCP [...]
The Alliance submitted a response to the Department of Justice Anticompetitive Regulations Task Force request for public comment to identify unnecessary laws and regulations that raise the highest barriers to competition. The Alliance for Connected Care (the “Alliance”) outlines four areas where we hope the Department of Justice Task Force will focus to improve care [...]
The Alliance submitted a response to the Federal Trade Commission's request for public comment regarding reducing anti-competitive regulatory barriers in health care. Our health care system is deeply impacted by anticompetitive practices. The Alliance appreciates the Federal Trade Commission’s long-standing work to reform occupational licensing regulations, removing anticompetitive practices. In particular, the FTC investigated options [...]
The Alliance appreciates the DEA’s forward movement on telemedicine prescribing of controlled substances policy. However, the Alliance continues to be concerned to see language in the proposed rulemaking mandating in-person visits as this is not an appropriate guardrail for a telehealth service. Similarly, restricting the geography in which telemedicine can be offered undermines the value [...]
The Alliance for Connected Care led a letter, signed by more than 150 organizations, to the Attorney General Pam Bondi requesting her leadership in maintaining the access to telehealth that President Trump initiated during his first term. More than 150 organizations have signed this letter, including business groups like the Small Business & Entrepreneurship Council and [...]
ALLIANCE STATEMENT DRUG ENFORCEMENT ADMINISTRATION (DEA) RELEASES SPECIAL REGISTRATION PROPOSAL JANUARY 2025 The Alliance for Connected Care appreciates the Drug Enforcement Administration’s (DEA) forward movement on telemedicine prescribing of controlled substances policy. Today, the DEA released a notice of proposed rulemaking, which would establish a special registration framework and authorize three types of special registrations [...]
FOR IMMEDIATE RELEASE MEDIA CONTACT Chris Adamec; cadamec@connectwithcare.org DRUG ENFORCEMENT ADMINISTRATION (DEA) RELEASES THIRD EXTENSION, ENSURING CERTAINTY AND ACCESS TO PATIENTS November 15, 2024 WASHINGTON DC – The Alliance for Connected Care applauds the third temporary extension of controlled substance prescribing via telemedicine rulemaking by the DEA. This one-year extension is an important step to [...]
Last week, we finally saw a proposed rule – “Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have not had a Prior In-Person Medical Evaluation” arrive at OMB. We expect that this proposed rule will avert the current end of telehealth prescribing flexibility on December 31, 2024. However, there remains significant risk [...]
Over 380 clinicians and practitioners signed a letter, requesting the DEA to issue a revised proposed rule to regulate the prescribing of controlled substances through telehealth as soon as possible to ensure adequate time for patients to continue existing care. To read a full copy of the stakeholder letter, please click here. [...]
FOR IMMEDIATE RELEASE Stakeholders Send Letter to DEA Urging Action on Telehealth Rule Crucial for Mental Health, Substance Use Disorders WASHINGTON, DC, APRIL 2, 2024 – The Alliance for Connected Care, American Telemedicine Association, ATA Action, the Consumer Technology Association, and the Healthcare Information and Management Systems Society, co-leading the effort, submitted a letter [...]